Results for tag: "Auto Transfusion Devices"

In the context of blood banking, the auto transfusion devices market comprises a niche segment focused on the collection and reinfusion of a patient's own blood. Blood banking traditionally involves the donation, storage, and distribution of donor blood for transfusions. Auto transfusion, however, provides an alternative to the use of banked donor blood during and after surgeries by allowing for the recapture and reuse of the patient's blood, thereby reducing the risk of transfusion-related infections, complications from immune response, and the dependency on the availability of donor blood. Auto transfusion devices are particularly advantageous in surgeries where there is a high expectation of blood loss, such as in cardiovascular and orthopedic procedures. These devices work by collecting blood that is lost during surgery, filtering and washing the blood, and then reinfusing it directly back into the patient. This technology is an essential part of intraoperative and postoperative patient care in settings where blood conservation is a priority. Several companies specialize in the development and manufacturing of auto transfusion devices, contributing to advances in this area of patient care. Prominent companies in the market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, LivaNova PLC, and Getinge AB. These enterprises offer a range of devices and systems designed to enhance the safety and efficiency of autologous blood transfusion processes. Show Less Read more